text
"['\n4. 재무제표\n재무상태표\n제 39 기\xa0 \xa0 \xa0 \xa0 \xa0 2020.12.31 현재\n제 38 기\xa0 \xa0 \xa0 \xa0 \xa0 2019.12.31 현재\n제 37 기\xa0 \xa0 \xa0 \xa0 \xa0 2018.12.31 현재\n(단위 : 원)\n\u3000\n제 39 기\n제 38 기\n제 37 기\n자산\n\u3000\n\u3000\n\u3000\n\u3000I. 유동자산\n609,042,506,447\n462,526,269,217\n540,817,852,611\n\u3000\u3000현금및현금성자산 (주4)\n8,021,194,791\n16,177,887,425\n32,476,801,250\n\u3000\u3000매출채권 (주6,36)\n261,009,125,267\n242,912,362,586\n274,401,980,758\n\u3000\u3000계약자산 (주20)\n\u3000\n3,625,608,045\n13,439,841,753\n\u3000\u3000기타수취채권 (주7,36)\n6,716,844,369\n4,436,783,544\n612,108,552\n\u3000\u3000선급비용\n3,755,685,771\n3,068,287,546\n5,950,114,576\n\u3000\u3000기타유동자산 (주9)\n31,437,392,176\n15,909,779,493\n21,962,986,994\n\u3000\u3000당기법인세자산\n\u3000\n579,792,405\n374,125,671\n\u3000\u3000재고자산 (주8)\n296,387,352,318\n169,812,719,304\n183,849,186,257\n\u3000\u3000기타금융자산 (주9)\n25,024,000\n\u3000\n\u3000\n\u3000\u3000파생상품자산 (주10)\n1,052,238,675\n6,003,048,869\n5,464,000,000\n\u3000\u3000매각예정자산 (주11)\n637,649,080\n\u3000\n2,286,706,800\n\u3000Ⅱ. 비유동자산\n1,617,691,557,205\n1,583,385,098,870\n1,567,804,176,352\n\u3000\u3000당기손익-공정가치측정 금융자산 (주12)\n203,669,160\n2,054,763,960\n2,166,561,993\n\u3000\u3000관계기업투자주식 (주13)\n5,648,671,382\n5,148,671,382\n5,148,671,382\n\u3000\u3000종속기업투자주식 (주14)\n216,553,699,507\n799,951,905,228\n757,338,041,157\n\u3000\u3000투자부동산 (주15)\n25,954,803,504\n\u3000\n\u3000\n\u3000\u3000유형자산 (주16)\n1,343,910,865,659\n752,092,134,310\n786,799,192,495\n\u3000\u3000무형자산 (주17)\n2,883,727,015\n2,718,556,519\n3,974,191,830\n\u3000\u3000사용권자산 (주18)\n9,746,132,975\n11,393,470,517\n\u3000\n\u3000\u3000장기매출채권 (주6,36)\n7,654,438,903\n648,463,846\n610,463,846\n\u3000\u3000기타수취채권 (주7,36)\n5,109,049,100\n9,342,318,408\n9,315,553,649\n\u3000\u3000기타금융자산 (주9)\n26,500,000\n34,814,700\n2,451,500,000\n\u3000자산총계\n2,226,734,063,652\n2,045,911,368,087\n2,108,622,028,963\n부채\n\u3000\n\u3000\n\u3000\n\u3000I. 유동부채\n468,057,393,765\n345,989,090,720\n633,095,766,681\n\u3000\u3000매입채무\n207,025,012,580\n175,729,453,827\n477,862,113,161\n\u3000\u3000단기차입금 (주23)\n207,239,037,782\n139,323,778,847\n133,443,340,802\n\u3000\u3000유동성장기차입금 (주23)\n\u3000\n1,061,271,960\n2,608,541,473\n\u3000\u3000선수금\n3,681,596,591\n4,946,807,262\n1,211,371,995\n\u3000\u3000계약부채 (주20)\n3,503,898,423\n4,770,350,679\n2,347,585,217\n\u3000\u3000미지급금\n14,664,265,489\n3,830,214,562\n3,400,190,724\n\u3000\u3000미지급비용\n18,188,880,693\n8,083,582,390\n8,472,622,998\n\u3000\u3000당기법인세부채 (주32)\n4,462,496,993\n\u3000\n\u3000\n\u3000\u3000기타유동부채 (주21)\n3,789,578,683\n3,091,187,351\n3,750,000,311\n\u3000\u3000리스부채 (주18)\n5,502,626,531\n5,152,443,842\n\u3000\n\u3000Ⅱ. 비유동부채\n802,213,260,303\n797,875,675,246\n1,460,323,466,411\n\u3000\u3000장기차입금 (주23)\n576,350,705,078\n565,252,008,730\n1,141,505,361,217\n\u3000\u3000사채 (주24)\n110,234,721,036\n107,701,060,398\n206,883,305,965\n\u3000\u3000확정급여부채 (주22)\n12,441,068,769\n23,930,292,808\n26,197,461,257\n\u3000\u3000이연법인세부채 (주32)\n82,986,058,740\n83,962,144,295\n83,962,144,295\n\u3000\u3000기타비유동부채 (주21)\n7,671,716,718\n1,991,772,179\n1,775,193,677\n\u3000\u3000리스부채 (주18)\n12,528,989,962\n15,038,396,836\n\u3000\n\u3000부채총계\n1,270,270,654,068\n1,143,864,765,966\n2,093,419,233,092\n자본\n\u3000\n\u3000\n\u3000\n\u3000자본금 (주25)\n555,311,410,000\n555,311,410,000\n191,967,900,000\n\u3000자본잉여금 (주25)\n340,254,146,373\n1,255,313,784,599\n700,212,317,289\n\u3000기타포괄손익누계액 (주25)\n797,596,916\n\u3000\n\u3000\n\u3000기타자본항목 (주25)\n40,748,098\n40,748,098\n142,010,520\n\u3000이익잉여금(결손금) (주27)\n60,059,508,197\n(908,619,340,576)\n(877,119,431,938)\n\u3000자본총계\n956,463,409,584\n902,046,602,121\n15,202,795,871\n자본과부채총계\n2,226,734,063,652\n2,045,911,368,087\n2,108,622,028,963\n※ 상기 재무제표는 주주총회 승인전 재무제표이며, 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.\n포괄손익계산서\n제 39 기 2020.01.01 부터 2020.12.31 까지\n제 38 기 2019.01.01 부터 2019.12.31 까지\n제 37 기 2018.01.01 부터 2018.12.31 까지\n(단위 : 원)\n\u3000\n제 39 기\n제 38 기\n제 37 기\n매출 (주37)\n2,098,691,005,565\n1,688,470,941,497\n1,750,903,867,403\n매출원가 (주28)\n1,926,999,335,187\n1,593,631,131,770\n1,682,033,190,575\n매출총이익\n171,691,670,378\n94,839,809,727\n68,870,676,828\n판매비와관리비 (주28,29)\n86,222,038,937\n74,376,531,102\n73,829,798,597\n영업이익\n85,469,631,441\n20,463,278,625\n(4,959,121,769)\n기타수익 (주30)\n2,787,233,569\n3,169,548,302\n2,170,063,434\n기타비용 (주30)\n17,033,966,648\n5,069,623,078\n13,573,388,561\n금융수익 (주31)\n41,942,136,350\n77,174,203,488\n157,246,217,535\n금융비용 (주31)\n71,788,620,648\n126,394,903,496\n151,107,705,544\n종속및관계기업투자와관련된이익\n\u3000\n\u3000\n5,150,000,000\n종속및관계기업투자와관련된손실\n\u3000\n\u3000\n(58,134,964,719)\n법인세비용차감전순손익\n41,376,414,064\n(30,657,496,159)\n(63,208,899,624)\n법인세비용(수익) (주32)\n1,057,198,512\n(203,863,820)\n(854,356,160)\n당기순손익\n42,433,612,576\n(30,861,359,979)\n(64,063,255,784)\n기타포괄손익\n18,423,492,537\n(638,548,659)\n(2,676,041,196)\n\u3000후속적으로 당기손익으로 재분류되지않는 포괄손익\n\u3000\n\u3000\n\u3000\n\u3000\u3000확정급여제도의 재측정요소 (주22)\n17,625,895,621\n(638,548,659)\n(2,676,041,196)\n\u3000후속적으로 당기손익으로 재분류되는 포괄손익\n\u3000\n\u3000\n\u3000\n\u3000\u3000현금흐름위험회피파생상품평가손익 (주10)\n797,596,916\n0\n\u3000\n총포괄손익\n60,857,105,113\n(31,499,908,638)\n(66,739,296,980)\n주당손익 (주26)\n\u3000\n\u3000\n\u3000\n\u3000보통주 기본 및 희석주당손익 (단위 : 원)\n424\n(857)\n(18,936)\n\u3000구형우선주 기본 및 희석주당손익 (단위 : 원)\n424\n(857)\n(18,936)\n※ 상기 재무제표는 주주총회 승인전 재무제표이며, 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.\n자본변동표\n제 39 기 2020.01.01 부터 2020.12.31 까지\n제 38 기 2019.01.01 부터 2019.12.31 까지\n제 37 기 2018.01.01 부터 2018.12.31 까지\n(단위 : 원)\n\u3000\n자본\n자본금\n자본잉여금\n기타포괄손익누계액\n이익잉여금\n기타자본항목\n자본\xa0 합계\n2018.01.01 (기초자본)\n180,802,285,000\n683,898,554,366\n\u3000\n(818,515,246,266)\n85,918,433\n46,271,511,533\n회계정책의 변경효과\n\u3000\n\u3000\n\u3000\n8,135,111,308\n\u3000\n8,135,111,308\n수정 후 재작성된 금액\n180,802,285,000\n683,898,554,366\n\u3000\n(810,380,134,958)\n85,918,433\n54,406,622,841\nI.총포괄손익 :\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n당기순손익\n\u3000\n\u3000\n\u3000\n(64,063,255,784)\n\u3000\n(64,063,255,784)\n현금흐름위험회피파생상품평가손익\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n확정급여제도의 재측정요소\n\u3000\n\u3000\n\u3000\n(2,676,041,196)\n\u3000\n(2,676,041,196)\nII.자본에 직접 인식된 주주와의 거래 :\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n무상감자\n(55,501,050,000)\n55,444,957,913\n\u3000\n\u3000\n56,092,087\n\u3000\n유상증자\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n출자전환\n66,666,665,000\n(39,131,194,990)\n\u3000\n\u3000\n\u3000\n27,535,470,010\n자기주식 거래로 인한 증감\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n종속회사합병\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n결손금보전\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n2018.12.31 (기말자본)\n191,967,900,000\n700,212,317,289\n\u3000\n(877,119,431,938)\n142,010,520\n15,202,795,871\n2019.01.01 (기초자본)\n191,967,900,000\n700,212,317,289\n\u3000\n(877,119,431,938)\n142,010,520\n15,202,795,871\n회계정책의 변경효과\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n수정 후 재작성된 금액\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\nI.총포괄손익 :\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n당기순손익\n\u3000\n\u3000\n\u3000\n(30,861,359,979)\n\u3000\n(30,861,359,979)\n현금흐름위험회피파생상품평가손익\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n확정급여제도의 재측정요소\n\u3000\n\u3000\n\u3000\n(638,548,659)\n\u3000\n(638,548,659)\nII.자본에 직접 인식된 주주와의 거래 :\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n무상감자\n(117,656,490,000)\n117,617,078,861\n\u3000\n\u3000\n37,411,139\n(2,000,000)\n유상증자\n360,000,000,000\n(8,448,588,750)\n\u3000\n\u3000\n\u3000\n351,551,411,250\n출자전환\n121,000,000,000\n445,932,977,199\n\u3000\n\u3000\n\u3000\n566,932,977,199\n자기주식 거래로 인한 증감\n\u3000\n\u3000\n\u3000\n\u3000\n(138,673,561)\n(138,673,561)\n종속회사합병\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n결손금보전\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n2019.12.31 (기말자본)\n555,311,410,000\n1,255,313,784,599\n\u3000\n(908,619,340,576)\n40,748,098\n902,046,602,121\n2020.01.01 (기초자본)\n555,311,410,000\n1,255,313,784,599\n\u3000\n(908,619,340,576)\n40,748,098\n902,046,602,121\n회계정책의 변경효과\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n수정 후 재작성된 금액\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\nI.총포괄손익 :\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n당기순손익\n\u3000\n\u3000\n\u3000\n42,433,612,576\n\u3000\n42,433,612,576\n현금흐름위험회피파생상품평가손익\n\u3000\n\u3000\n797,596,916\n\u3000\n\u3000\n797,596,916\n확정급여제도의 재측정요소\n\u3000\n\u3000\n\u3000\n17,625,895,621\n\u3000\n17,625,895,621\nII.자본에 직접 인식된 주주와의 거래 :\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n무상감자\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n유상증자\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n출자전환\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n자기주식 거래로 인한 증감\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n종속회사합병\n\u3000\n(6,440,297,650)\n\u3000\n\u3000\n\u3000\n(6,440,297,650)\n결손금보전\n\u3000\n(908,619,340,576)\n\u3000\n908,619,340,576\n\u3000\n\u3000\n2020.12.31 (기말자본)\n555,311,410,000\n340,254,146,373\n797,596,916\n60,059,508,197\n40,748,098\n956,463,409,584\n※ 상기 재무제표는 주주총회 승인전 재무제표이며, 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.\n현금흐름표\n제 39 기 2020.01.01 부터 2020.12.31 까지\n제 38 기 2019.01.01 부터 2019.12.31 까지\n제 37 기 2018.01.01 부터 2018.12.31 까지\n(단위 : 원)\n\u3000\n제 39 기\n제 38 기\n제 37 기\nI. 영업활동으로 인한 현금흐름\n82,729,155,441\n(163,380,632,541)\n(5,818,807,481)\n\u30001. 영업활동에서 창출된 현금흐름(주석33)\n82,651,694,248\n(164,316,618,364)\n(6,093,436,839)\n\u3000\u3000(1) 당기순손익\n42,433,612,576\n(30,861,359,979)\n(64,063,255,784)\n\u3000\u3000(2) 조정\n99,886,341,691\n88,143,021,280\n100,739,873,413\n\u3000\u3000(3) 영업활동으로 인한 자산부채의 변동\n(59,668,260,019)\n(221,598,279,665)\n(42,770,054,468)\n\u30002. 이자의 수취\n236,728,516\n1,141,652,557\n328,906,254\n\u30003. 배당금의 수취\n7,000,000\n\u3000\n0\n\u30004. 법인세의 납부\n(166,267,323)\n(205,666,734)\n(54,276,896)\nⅡ. 투자활동으로 인한 현금흐름\n(26,335,862,696)\n(60,322,068,116)\n(9,965,788,784)\n\u3000기타유동수취채권의 증가\n(38,150,379,298)\n(3,531,000,000)\n1,077,209,091\n\u3000기타유동금융자산의 감소\n7,810,000,000\n\u3000\n\u3000\n\u3000파생상품금융자산의 처분\n13,473,811,620\n\u3000\n\u3000\n\u3000매각예정자산의 처분\n\u3000\n2,058,036,120\n\u3000\n\u3000당기손익-공정가치금융자산의 취득\n\u3000\n(2,666,667)\n\u3000\n\u3000당기손익-공정가치측정 금융자산의 처분\n1,692,350,000\n\u3000\n2,996,000,000\n\u3000상각후원가측정 금융자산(비유동)의 처분\n\u3000\n\u3000\n250,000,000\n\u3000종속기업투자주식의 취득\n(5,000,000,000)\n(42,472,864,071)\n\u3000\n\u3000관계기업투자주식의 취득\n(500,000,000)\n\u3000\n\u3000\n\u3000종속기업투자주식의 처분\n42,589,089,141\n\u3000\n\u3000\n\u3000배당금수익\n1,637,458,164\n4,000,000\n5,154,000,000\n\u3000종속기업 합병에 따른 현금유입\n8,681,882,950\n\u3000\n\u3000\n\u3000유형자산의 취득\n(64,548,613,593)\n(18,938,476,153)\n(18,813,335,016)\n\u3000유형자산의 처분\n56,447,140\n110,893,000\n86,244,849\n\u3000무형자산의 취득\n(434,384,390)\n\u3000\n\u3000\n\u3000무형자산의 처분\n395,454,545\n\u3000\n\u3000\n\u3000기타비유동수취채권의 증가\n\u3000\n\u3000\n(1,198,723,056)\n\u3000기타비유동수취채권의 감소\n5,681,021,025\n33,324,355\n746,815,348\n\u3000기타비유동금융자산의 증가\n(80,000,000)\n(13,314,700)\n(264,000,000)\n\u3000기타비유동금융자산의 감소\n360,000,000\n2,430,000,000\n\u3000\nⅢ. 재무활동으로 인한 현금흐름\n(64,549,985,379)\n207,403,786,832\n(18,864,498,190)\n\u3000단기차입금의 순증감\n(33,910,409,200)\n10,137,055,152\n41,814,610,209\n\u3000장기차입금의 차입\n\u3000\n\u3000\n32,666,627,042\n\u3000유동성장기차입금의 상환\n(1,061,271,960)\n(772,427,700)\n(35,671,080,421)\n\u3000유동성사채의 상환\n\u3000\n(5,571,300,000)\n(1,724,177,862)\n\u3000장기차입금의 상환\n(2,148,282,860)\n(103,343,392,500)\n\u3000\n\u3000리스부채의 상환\n(3,894,215,992)\n(2,196,363,656)\n\u3000\n\u3000이자의 지급\n(23,535,805,367)\n(41,616,748,403)\n(55,605,947,168)\n\u3000유상증자\n\u3000\n360,000,000,000\n\u3000\n\u3000주식발행비용(출자전환비용)\n\u3000\n(9,094,362,500)\n(344,529,990)\n\u3000자기주식의 취득\n\u3000\n(138,673,561)\n\u3000\nⅣ.현금및현금성자산의 순증감(Ⅰ+Ⅱ+Ⅲ)\n(8,156,692,634)\n(16,298,913,825)\n(34,649,094,455)\nⅤ.기초 현금및현금성자산\n16,177,887,425\n32,476,801,250\n67,125,895,705\nⅦ.기말 현금및현금성자산(Ⅳ+Ⅴ+Ⅵ))\n8,021,194,791\n16,177,887,425\n32,476,801,250\n※ 상기 재무제표는 주주총회 승인전 재무제표이며, 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.\n이익잉여금처분계산서\n제 39 기 2020.01.01 부터 2020.12.31 까지\n제 38 기 2019.01.01 부터 2019.12.31 까지\n제 37 기 2018.01.01 부터 2018.12.31 까지\n(단위 : 원)\n과\xa0\xa0 목\n제 39 기\n제 38 기\n제 37 기\n처리예정일: 2021년 3월 19일\n처리확정일: 2020년 3월 27일\n처리확정일 : 2019년 3월 29일(*)\nⅠ. 미처분이익잉여금(미처리결손금)\n\u3000\n60,059,508,197\xa0\n\u3000\n\xa0(908,619,340,576)\xa0\n\u3000\n\xa0(877,119,431,938)\xa0\n\xa0 전기이월이익잉여금(전기이월결손금)\n-\n\u3000\n\xa0(877,119,431,938)\xa0\n\u3000\n\xa0(818,515,246,266)\xa0\n\u3000\n\xa0 기준서변경효과\n\u3000\n\u3000\n\u3000\n\u3000\n8,135,111,308\xa0\n\u3000\n\xa0 당기순이익(손실)\n42,433,612,576\xa0\n\u3000\n\xa0(30,861,359,979)\xa0\n\u3000\n\xa0(64,063,255,784)\xa0\n\u3000\n\xa0 순확정급여부채의 재측정요소\n17,625,895,621\xa0\n\u3000\n\xa0(638,548,659)\xa0\n\u3000\n\xa0(2,676,041,196)\xa0\n\u3000\nⅡ. 임의적립금등의 이입액\n\u3000\n-\n\u3000\n908,619,340,576\xa0\n\u3000\n-\n\xa0 자본잉여금의 이입\n\u3000\n\u3000\n908,619,340,576\xa0\n\u3000\n\u3000\n\u3000\nⅢ. 이익잉여금처분액\n\u3000\n11,008,950,975\xa0\n\u3000\n-\n\u3000\n-\n\xa0 이익준비금\n1,000,813,725\xa0\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0 현금배당(당기) :\xa0\n\xa0\xa0 보통주 1주당 100원(2%)\xa0\xa0 우선주 1주당\xa0 150원(3%)\n10,008,137,250\xa0\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\nⅣ. 차기이월미처분이익잉여금\n\u3000\n49,050,557,222\xa0\n\u3000\n-\xa0\n\u3000\n(877,119,431,938)\n(*) 당사는 제 37기 재무제표를 재작성 하였으며, 상기 처분계산서는 재작성효과를 고려하여 수정되었습니다.※ 상기 재무제표는 주주총회 승인전 재무제표이며, 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.\n']"
